Effect of GLP-1 Receptors Agonist Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Lixisenatide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Sanofi
- 07 Jun 2017 Biomarkers information updated
- 27 Jan 2017 Status changed from completed to discontinued.
- 26 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.